Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-23, Stock:LLY, The news for the past five days is as follows:
2021-12-16: NEWS1: 2 Pharma Names Throwing Off Big Dividend Increases.NEWS2: With Improved Guidance, Eli Lilly and Company (NYSE:LLY) Appears to be Trading at the Right Price.NEWS3: Eli Lilly (LLY) Just Reclaimed the 20-Day Moving Average.NEWS4: Eli Lilly (LLY) Just Reclaimed the 50-Day Moving Average.NEWS5: Company News for Dec 16, 2021.NEWS6: Lilly (LLY) Stock Up on Raised 2021 View, Upbeat 2022 Guidance.NEWS7: Dow Jones Futures Rise After Market Roars On Fed Move; AMD, Nvidia, Lilly Flash Buy Signals.NEWS8: Securian Funds Trust Buys VF Corp, Sells Eli Lilly and Co.NEWS9: Lilly (LLY) Stock Jumps 10.4%: Will It Continue to Soar?.NEWS10: Dow Jones Futures: Market Roars On This Fed Move; AMD, Nvidia, Lilly Flash Buy Signals.
2021-12-17: NEWS1: The Funded: A court fight over Johnson & Johnson's $3.4B Auris Health acquisition is going forward.NEWS2: Stock Market Rallies After Fed Meeting, But Not For Long; Adobe, Rivian, Eli Lilly In Focus: Weekly Review.NEWS3: Pharma Stock Roundup: PFE Announces Arena Buyout, LLY Ups 2021 View & More.NEWS4: Biogen (BIIB) to Begin Aduhelm Confirmatory Study in 2022.NEWS5: Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week.
2021-12-20: NEWS1: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS2: Biogen Slashes Alzheimer's Treatment Price Amid Launch 'Gone Awry'.NEWS3: Market check: Stocks open lower, yield curve steepens, oil under pressure.NEWS4: Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply.
2021-12-21: NEWS1: Biogen (BIIB) to Cut Alzheimer's Drug Aduhelm Price by 50%.NEWS2: Eli Lilly's (NYSE:LLY) Shareholders Will Receive A Bigger Dividend Than Last Year.NEWS3: Lilly's lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study.
2021-12-22: NEWS1: Top Research Reports for Microsoft, Broadcom & Eli Lilly.NEWS2: COVID SCIENCE-Common health issues raise risk for severe COVID-19; sudden food aversion in toddlers may be due to COVID.NEWS3: Lilly's (LLY) Eczema Study on Lebrikizumab Combo Meets Goal.NEWS4: Will Lilly and Pfizer be Top Pharma Stocks Again in 2022?.

Answer: Rise